Advertisement

LB Pharmaceuticals Inc LBRX

Set alert

Price alert · LBRX

All alert types
39.70 USD -0.45 -1.12%

At close · Oct 30

40.20 +0.50 +1.26%

After hours · Oct 30, 4:15 PM ET

Bid
39.66 × 2
Ask
39.77 × 2
39.13 Day range 41.24
14.61 52-week range 49.48
YTD
+78.35%
1 year
+143.86%
Open
40.10
Prev close
40.15
Mkt cap
1.28B
Vol
429.47K
Avg vol
366.85K
EPS
0.10
P/E
397.00
Div yield
0.00%
More statistics
Low
39.13
High
41.24
Forward P/E
-7.74
Beta
0.00
Short ratio
12.64
Inst. own
102.37%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
41.53
200-d avg
32.47
1y target
58.00

5D chart

Chart tools
Interval

Signals (120)
NameTimeAgo
RSI: OversoldOct 30, 1:20 PM2 days ago
SMA: BearishOct 30, 12:45 PM2 days ago
SMA: BullishOct 30, 12:20 PM2 days ago
SMA: BullishOct 30, 12:15 PM2 days ago
SMA: BearishOct 30, 11:40 AM2 days ago
MACD: Sell SignalOct 30, 11:30 AM2 days ago
SMA: BearishOct 30, 11:25 AM2 days ago
RSI: OverboughtOct 30, 10:50 AM2 days ago
RSI: OverboughtOct 30, 10:40 AM2 days ago
MACD: Buy SignalOct 30, 10:35 AM2 days ago
SMA: BullishOct 30, 10:25 AM2 days ago
MACD: Sell SignalOct 30, 10:05 AM2 days ago
SMA: BearishOct 30, 9:45 AM2 days ago
RSI: OverboughtOct 29, 3:50 PM2 days ago
SMA: BullishOct 29, 3:15 PM2 days ago
SMA: BullishOct 29, 2:50 PM2 days ago
MACD: Buy SignalOct 29, 2:40 PM2 days ago
SMA: BearishOct 29, 2:30 PM2 days ago
SMA: BullishOct 29, 2:25 PM2 days ago
MACD: Sell SignalOct 29, 1:50 PM2 days ago
SMA: BearishOct 29, 1:35 PM2 days ago
SMA: BearishOct 29, 1:35 PM2 days ago
SMA: BullishOct 29, 1:30 PM2 days ago
SMA: BullishOct 29, 1:15 PM3 days ago
SMA: BearishOct 29, 1:10 PM3 days ago
MACD: Buy SignalOct 29, 12:55 PM3 days ago
SMA: BullishOct 29, 12:50 PM3 days ago
SMA: BearishOct 29, 12:30 PM3 days ago
SMA: BullishOct 29, 12:20 PM3 days ago
SMA: BearishOct 29, 11:35 AM3 days ago
SMA: BullishOct 29, 11:20 AM3 days ago
SMA: BearishOct 29, 11:15 AM3 days ago
SMA: BullishOct 29, 11:10 AM3 days ago
SMA: BearishOct 29, 10:50 AM3 days ago
MACD: Sell SignalOct 29, 10:15 AM3 days ago
SMA: BearishOct 29, 10:05 AM3 days ago
SMA: BullishOct 28, 3:30 PM3 days ago
SMA: BullishOct 28, 3:30 PM3 days ago
MACD: Buy SignalOct 28, 3:30 PM3 days ago
SMA: BearishOct 28, 3:10 PM3 days ago
MACD: Sell SignalOct 28, 3:10 PM3 days ago
MACD: Buy SignalOct 28, 3:05 PM3 days ago
SMA: BullishOct 28, 3:00 PM3 days ago
SMA: BearishOct 28, 2:40 PM3 days ago
SMA: BullishOct 28, 2:35 PM3 days ago
MACD: Sell SignalOct 28, 1:40 PM3 days ago
SMA: BearishOct 28, 1:35 PM3 days ago
SMA: BearishOct 28, 1:35 PM3 days ago
MACD: Buy SignalOct 28, 1:25 PM3 days ago
SMA: BullishOct 28, 1:15 PM4 days ago
SMA: BullishOct 28, 1:15 PM4 days ago
SMA: BearishOct 28, 1:05 PM4 days ago
SMA: BearishOct 28, 1:05 PM4 days ago
SMA: BullishOct 28, 12:50 PM4 days ago
SMA: BullishOct 28, 12:50 PM4 days ago
SMA: BearishOct 28, 12:45 PM4 days ago
SMA: BullishOct 28, 12:40 PM4 days ago
SMA: BearishOct 28, 12:20 PM4 days ago
SMA: BearishOct 28, 12:10 PM4 days ago
SMA: BullishOct 28, 12:00 PM4 days ago
SMA: BearishOct 28, 11:55 AM4 days ago
SMA: BullishOct 28, 11:45 AM4 days ago
MACD: Sell SignalOct 28, 11:35 AM4 days ago
SMA: BearishOct 28, 11:25 AM4 days ago
SMA: BullishOct 28, 10:40 AM4 days ago
SMA: BearishOct 28, 10:35 AM4 days ago
SMA: BullishOct 28, 10:05 AM4 days ago
SMA: BullishOct 28, 10:05 AM4 days ago
SMA: BearishOct 28, 10:00 AM4 days ago
SMA: BearishOct 28, 10:00 AM4 days ago
SMA: BullishOct 28, 9:55 AM4 days ago
MACD: Buy SignalOct 28, 9:55 AM4 days ago
SMA: BearishOct 28, 9:30 AM4 days ago
SMA: BullishOct 27, 3:55 PM4 days ago
SMA: BearishOct 27, 3:45 PM4 days ago
MACD: Sell SignalOct 27, 3:45 PM4 days ago
SMA: BearishOct 27, 3:40 PM4 days ago
SMA: BullishOct 27, 3:00 PM4 days ago
SMA: BullishOct 27, 3:00 PM4 days ago
SMA: BearishOct 27, 2:55 PM4 days ago
SMA: BearishOct 27, 2:55 PM4 days ago
SMA: BullishOct 27, 2:50 PM4 days ago
SMA: BullishOct 27, 2:50 PM4 days ago
SMA: BearishOct 27, 2:45 PM4 days ago
SMA: BearishOct 27, 2:45 PM4 days ago
SMA: BullishOct 27, 2:35 PM4 days ago
SMA: BullishOct 27, 2:35 PM4 days ago
SMA: BearishOct 27, 2:10 PM4 days ago
SMA: BullishOct 27, 2:05 PM4 days ago
MACD: Buy SignalOct 27, 2:05 PM4 days ago
MACD: Sell SignalOct 27, 1:40 PM4 days ago
SMA: BearishOct 27, 1:35 PM4 days ago
MACD: Buy SignalOct 27, 1:30 PM4 days ago
SMA: BullishOct 27, 1:20 PM5 days ago
SMA: BearishOct 27, 1:05 PM5 days ago
SMA: BullishOct 27, 12:55 PM5 days ago
SMA: BearishOct 27, 12:20 PM5 days ago
MACD: Sell SignalOct 27, 11:30 AM5 days ago
SMA: BearishOct 27, 11:15 AM5 days ago
SMA: BullishOct 27, 10:10 AM5 days ago
MACD: Buy SignalOct 27, 9:55 AM5 days ago
SMA: BullishOct 27, 9:40 AM5 days ago
SMA: BearishOct 27, 9:30 AM5 days ago
RSI: OversoldOct 27, 9:30 AM5 days ago
SMA: BullishOct 26, 3:55 PM5 days ago
SMA: BullishOct 26, 2:20 PM5 days ago
SMA: BearishOct 26, 2:15 PM5 days ago
SMA: BearishOct 26, 1:40 PM5 days ago
SMA: BullishOct 26, 1:30 PM5 days ago
SMA: BearishOct 26, 1:25 PM5 days ago
SMA: BearishOct 26, 1:20 PM6 days ago
SMA: BullishOct 26, 1:15 PM6 days ago
SMA: BullishOct 26, 1:15 PM6 days ago
SMA: BearishOct 26, 1:05 PM6 days ago
SMA: BearishOct 26, 12:45 PM6 days ago
MACD: Sell SignalOct 26, 12:45 PM6 days ago
SMA: BullishOct 26, 11:55 AM6 days ago
SMA: BearishOct 26, 11:30 AM6 days ago
SMA: BullishOct 26, 10:50 AM6 days ago
SMA: BearishOct 26, 10:25 AM6 days ago

Key statistics

Market cap
1.28B
Enterprise value
972.63M
Trailing P/E
397.00
Forward P/E
-7.74
PEG ratio
0.00
Price / sales
0.00
Price / book
3.43
EPS (TTM)
0.10
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-53.92M
Total cash
327.79M
Total debt
5.22M
Return on equity
-50.00%
Shares outstanding
32.26M
Short % of float
20.29%
50-day average
41.53
200-day average
32.47

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 58.00 +46.1% upside
Target (low)
35.00
Target (mean)
58.00
Target (high)
80.00
Ratings (0m) 11 10 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy8
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate -1.52.

Earnings history

Financials — quick view

All financials
LBRX Revenue — quarterly 0
2024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LBRX Net income — quarterly -51.60M
2024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LBRX EPS — quarterly -1.71
2024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

LBRX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 2026-1.62———
Aug 11, 2026Jun 30, 2026-0.80366-1.71-0.91-112.78%
May 12, 2026Mar 31, 2026-0.75-0.67+0.08+10.67%
Mar 26, 2026Dec 31, 2025-0.45-0.450.000.00%
Nov 6, 2025Sep 30, 2025-0.57-0.61-0.04-7.02%
Sep 8, 2025Jun 30, 2025—-1.44——

Upgrades / downgrades

LBRX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 9, 2026Canaccord Genuityinit—Buy
Oct 6, 2026Guggenheiminit—Buy
Oct 5, 2026Roth CapitaldownBuyNeutral
Oct 2, 2026Needhaminit—Buy
Aug 24, 2026HC Wainwright & Co.mainBuyBuy
Aug 12, 2026BMO CapitalmainOutperformOutperform

About LB Pharmaceuticals Inc

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
lbpharma.us

News

Your note

Sign in to keep a note on LBRX — it syncs with the Stock Master app.

Insider holders

LBRX insider holders
InsiderRelationLatest transactionDateShares held
DEEP TRACK BIOTECHNOLOGY MASTER FUND LTDBeneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securitySep 11, 20250
NUSSBAUM RANDirectorConversion of Exercise of derivative securitySep 11, 20250
PONTIFAX MANAGEMENT 4 G.P. 2015, LTD.Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securitySep 11, 20250
VIDA VENTURES GP III, L.L.C.Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securitySep 11, 20250

Institution ownership

LBRX institution ownership
Holder% heldSharesValueReported
Deep Track Capital, Lp10.39%3,352,804133.11MJun 29, 2026
Blackrock Inc.8.48%2,734,305108.55MJun 29, 2026
RA Capital Management, L.P.6.85%2,208,60487.68MJun 29, 2026
Trails Edge Capital Partners, LP4.72%1,523,02260.46MJun 29, 2026
Commodore Capital Lp4.65%1,500,00059.55MJun 29, 2026
JPMORGAN CHASE & CO4.64%1,497,29359.44MJun 29, 2026

Fund ownership

LBRX fund ownership
Holder% heldSharesValueReported
JPMorgan Trust II-JPMorgan Small Cap Growth Fund2.15%692,90527.51MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.08%672,00026.68MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF1.80%581,67723.09MSep 29, 2026
BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio1.76%567,62722.53MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund0.86%278,88711.07MJun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund0.76%244,9109.72MJul 30, 2026
Advertisement